Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
D Ginsburg, … , R V Lebo, T D Gelehrter
D Ginsburg, … , R V Lebo, T D Gelehrter
Published December 1, 1986
Citation Information: J Clin Invest. 1986;78(6):1673-1680. https://doi.org/10.1172/JCI112761.
View: Text | PDF
Research Article Article has an altmetric score of 6

cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

  • Text
  • PDF
Abstract

Full-length cDNA for plasminogen activator inhibitor (PAI-1) was isolated from a human umbilical vein endothelial cell (HUVEC) lambda gt11 cDNA library. Three overlapping clones were identified by immunologic screening of 10(6) recombinant phage using a rabbit anti-human fibrosarcoma PAI-1 antiserum. The fusion proteins encoded by these three clones also react strongly with a monoclonal mouse anti-human fibrosarcoma PAI-1 antibody. By nucleotide sequence analysis, PAI-1 cDNA encodes a protein containing 402 amino acids with a predicted, nonglycosylated molecular mass of 45 kD. Identity of this material as authentic PAI-1 was confirmed by the presence of high level homology with the primary amino acid sequence of an internal peptide prepared from purified rat hepatoma PAI-1. The predicted amino acid sequence also reveals extensive homology with other members of the serine protease inhibitor gene family. Cultured HUVECs contain two PAI-1 mRNA species, both encoded by a single gene, differing by 1 kb in the 3' untranslated region. The PAI-1 gene is located on human chromosome 7.

Authors

D Ginsburg, R Zeheb, A Y Yang, U M Rafferty, P A Andreasen, L Nielsen, K Dano, R V Lebo, T D Gelehrter

×

Total citations by year

Year: 2024 2022 2021 2020 2018 2017 2016 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1953 Total
Citations: 1 2 1 2 1 1 1 2 3 7 2 2 1 1 4 3 2 7 7 4 6 14 8 11 20 6 20 10 9 13 11 16 26 25 10 1 260
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (260)

Title and authors Publication Year
Genetics of Hemostasis: from Bedside to Bench and Back Again
David Ginsburg
Journal of Clinical Investigation 2024
Myxomavirus Serp-1 Protein Ameliorates Inflammation in a Mouse Model of Duchenne Muscular Dystrophy.
Andre AB, Zhang L, Nix JD, Elmadbouly N, Lucas AR, Wilson-Rawls J, Rawls A
Biomedicines 2022
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism.
Wang Z, Kong L, Luo G, Zhang H, Sun F, Liang W, Wu W, Guo Z, Zhang R, Dou Y
Thrombosis Journal 2022
Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy
AG Bharadwaj, RW Holloway, VA Miller, DM Waisman
Cancers 2021
PAI-1, the Plasminogen System, and Skeletal Muscle
FA Rahman, MP Krause
International journal of molecular sciences 2020
Plasminogen activator inhibitor‐1: a potential etiological role in livedoid vasculopathy
Y Gao, H Jin
International Wound Journal 2020
Role of plasminogen activator inhibitor-1 in coronary pathophysiology
RG Jung, T Simard, A Labinaz, FD Ramirez, PD Santo, P Motazedian, R Rochman, C Gaudet, MA Faraz, RS Beanlands, B Hibbert
Thrombosis Research 2018
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of SenescenceHighlights
DE Vaughan, R Rai, SS Khan, M Eren, AK Ghosh
Arteriosclerosis, thrombosis, and vascular biology 2017
Encyclopedia of Signaling Molecules
S Choi
Encyclopedia of Signaling Molecules 2016
Functional Stability of Plasminogen Activator Inhibitor-1
SY Yildiz, P Kuru, ET Oner, M Agirbasli
The Scientific World JOURNAL 2014
The plasminogen activation system in periodontal tissue (Review)
M Wyganowska-Świątkowska, A Surdacka, E Skrzypczak-Jankun, J Jankun
International journal of molecular medicine 2014
Genetic background of idiopathic pulmonary fibrosis
S Santangelo, S Scarlata, A Zito, D Chiurco, C Pedone, RA Incalzi
Expert Review of Molecular Diagnostics 2013
The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience
M Heiman, S Gupta, AD Shapiro
Haemophilia 2013
Sputum Plasminogen Activator Inhibitor-1 Elevation by Oxidative Stress-Dependent Nuclear Factor-κB Activation in COPD
M To, D Takagi, K Akashi, I Kano, K Haruki, PJ Barnes, K Ito
Chest 2013
Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy
SR Han, CJ Kim, BC Lee
Experimental and therapeutic medicine 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Hémostase locale en chirurgie orale. 1<sup>ère</sup> partie : physiologie de l’hémostase
Y Nizamaldin, SA Najm, ME Hage, J Samson
Médecine Buccale Chirurgie Buccale 2012
Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells
S Iwaki, S Yamamura, M Asai, BE Sobel, S Fujii
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2012
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
BV de Craen, PJ Declerck, A Gils
Thrombosis Research 2012
Fibrinolytic system in preeclampsia
MB Pinheiro, KB Gomes, LM Dusse
Clinica Chimica Acta 2012
Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease
TM Simone, PJ Higgins
2012
The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles
Q Jiang, NA Gingles, MA Olivier, LA Miles, RJ Parmer
Blood 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken
Advances in Cancer Research Volume 110 2011
Relations du système plasminogène-plasmine et cancer
PM Martin, C Dussert, S Romain, LH Ouafik
Oncologie 2010
The ovine plasminogen activator inhibitors type 1 and type 2 cDNAs: Molecular cloning, characterization and expression in various tissues
G Theodorou, I Bizelis, E Rogdakis, I Politis
Gene 2010
Plasminogen activator inhibitor 1 gene polymorphisms and mirtazapine responses in Koreans with major depression
HS Chang, HY Lee, BJ Ham, RH Kang, YJ Jeong, HM Kim, SW Hahn, MS Lee
ASIA-PAC PSYCHIAT 2009
Role of Tissue-Type Plasminogen Activator in Salicylic Acid–Induced Sloughing of Human Corn Tissue
GD Heda, LK Roberts
J AM PODIAT MED ASSN 2008
Hydroxyapatite formed on/in agarose gel induces activation of blood coagulation and platelets aggregation
S Arimura, K Kawahara, KK Biswas, K Abeyama, M Tabata, T Shimoda, D Ogomi, M Matsusaki, S Kato, T Ito, K Sugihara, M Akashi, T Hashiguchi, I Maruyama
Journal of Biomedical Materials Research Part B: Applied Biomaterials 2007
Differential Release of Plasminogen Activator Inhibitors (PAIs) During Dual Perfusion of Human Placenta: Implications in Preeclampsia
S Guller, Y Ma, A Malek, SD Santo, H Schneider
Placenta 2007
Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer
R Castelló, JM Landete, F España, C Vázquez, C Fuster, SM Almenar, LA Ramón, KP Radtke, A Estellés
Thrombosis Research 2007
Post-Genomic Cardiology
J Marín-García, MJ Goldenthal, GW Moe
Post-Genomic Cardiology 2007
Design and screening of antisense oligodeoxynucleotides against PAI-1 mRNA in endothelial cells in vitro1
Q JIANG, S WANG
Acta Pharmacologica Sinica 2006
Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity
R Castelló, F España, C Vázquez, C Fuster, SM Almenar, J Aznar, A Estellés
Thrombosis Research 2006
ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells
HK Hong, CY Song, BC Kim, HS Lee
Translational Research 2006
Pivotal role of plasminogen-activator inhibitor 1 in vascular disease
M Agirbasli
International Journal of Clinical Practice 2005
Iron-mediated stability of PAI-1 mRNA in adenocarcinoma cells—involvement of a mRNA-binding nuclear protein
KS Radha, M Sugiki, E Yoshida, MH Kumar, S Omura, M Maruyama
Thrombosis Research 2005
Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue
R Hildenbrand, N Arens
British Journal of Cancer 2004
Preservation of the Characteristics of the Cultured Human Type II Alveolar Epithelial Cells
K Takahashi, M Mitsui, K Takeuchi, Y Uwabe, K Kobayashi, Y Sawasaki, T Matsuoka
Lung 2004
Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance
AJ Horrevoets
British Journal of Haematology 2004
Inhibition of plasminogen activator inhibitor-1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs
K Verbeke, A Gils, PJ Declerck
Journal of Thrombosis and Haemostasis 2004
Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility
BD Taeye, A Gils, N Vleugels, A Rabijns, PJ Declerck
Biochemical and Biophysical Research Communications 2004
19 F NMR Studies of Plasminogen Activator Inhibitor-1
GL Abbott, GE Blouse, MJ Perron, JD Shore, LA Luck, AG Szabo
Biochemistry 2004
Expression profiles of fibrinolytic components in nasal mucosa
T Sejima, S Madoiwa, J Mimuro, T Sugo, T Ishida, K Ichimura, Y Sakata
Histochemistry and Cell Biology 2004
Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases
Q Wang, S Shaltiel
BMC Biochemistry 2003
Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1
S Verheyden, A Sillen, A Gils, PJ Declerck, Y Engelborghs
Biophysical Journal 2003
Astrocyte regulation of human brain capillary endothelial fibrinolysis
JA Kim, ND Tran, SJ Wang, MJ Fisher
Thrombosis Research 2003
Tryptophan Properties in Fluorescence and Functional Stability of Plasminogen Activator Inhibitor 1
S Verheyden, A Sillen, A Gils, PJ Declerck, Y Engelborghs
Biophysical Journal 2003
Structural determinants in the stability of the serpin/proteinase complex
BD Taeye, K Verbeke, G Compernolle, W Biesemans, A Gils, PJ Declerck
Biochemical and Biophysical Research Communications 2003
Constitutive Activation of rac 1 Results in Mitochondrial Oxidative Stress and Induces Premature Endothelial Cell Senescence
SS Deshpande, B Qi, YC Park, K Irani
Arteriosclerosis, thrombosis, and vascular biology 2003
Plasminogen: Structure, Activation, and Regulation
DM Waisman
2003
Post-Transcriptional Regulation of Gene Expression in the Plasminogen Activation System
N Montuori, G Rossi, P Ragno
Biological Chemistry 2002
Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis
K Hamano, M Iwano, Y Akai, H Sato, A Kubo, Y Nishitani, H Uyama, Y Yoshida, M Miyazaki, H Shiiki, S Kohno, K Dohi
American Journal of Kidney Diseases 2002
The active fraction of plasmatic plasminogen activator inhibitor type 1 as a possible indicator of increased risk for metastatic melanoma
GS Hanekom, HM Stubbings, SH Kidson
Cancer Detection and Prevention 2002
Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury
Y Tahashi
Hepatology 2002
Increased expression of the Zn-finger transcription factor BTEB1 in human endometrial cells is correlated with distinct cell phenotype, gene expression patterns, and proliferative responsiveness to serum and TGF-β1
XL Zhang, FA Simmen, FJ Michel, RC Simmen
Molecular and Cellular Endocrinology 2001
Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression
FW Frueh, KC Hayashibara, PO Brown, JP Whitlock
Toxicology Letters 2001
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system
G Fibbi, M Pucci, S D'Alessio, C Grappone, G Pellegrini, R Salzano, A Casini, S Milani, MD Rosso
Growth Factors 2001
The Distal Hinge of the Reactive Site Loop and Its Proximity: A TARGET TO MODULATE PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY
AP Bijnens, A Gils, JM Stassen, AA Komissarov, I Knockaert, E Brouwers, JD Shore, PJ Declerck
The Journal of biological chemistry 2001
Recombinant Semliki Forest virus enhanced plasminogen activator inhibitor 1 expression and storage in the megakaryocytic cell line MEG-01
JL Chuang, RR Schleef
Journal of Cellular Biochemistry 2001
Human L1 Retrotransposition: cisPreference versus trans Complementation
W Wei, N Gilbert, SL Ooi, JF Lawler, EM Ostertag, HH Kazazian, JD Boeke, JV Moran
Molecular and cellular biology 2001
Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26
WS Chang, NT Chang, SC Lin, CW Wu, FY Wu
Genes, Chromosomes and Cancer 2000
Induction of endometrial plasminogen activator–inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia
EM Rutanen, R Hurskainen, P Finne, K Nokelainen
Fertility and Sterility 2000
Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells
SM Wileman, NA Booth, N Moore, B Redmill, JV Forrester, RM Knott
The British journal of ophthalmology 2000
Post-transcriptional regulation of endothelial cell plasminogen activator inhibitor-1 expression during R. rickettsii infection
RJ Shi, PJ Simpson-Haidaris, VJ Marder, DJ Silverman, LA Sporn
Microbial Pathogenesis 2000
Emerging regulatory mechanisms for fibrinolytic gene expression
M Koziczak, L Montero, F Maurer, Y Nagamine
Fibrinolysis and Proteolysis 2000
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation
H Nar, M Bauer, JM Stassen, D Lang, A Gils, PJ Declerck
Journal of Molecular Biology 2000
PAI-1 stability: the role of histidine residues
H Mångs, GC Sui, B Wiman
FEBS Letters 2000
Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice
YC Jang, R Tsou, NS Gibran, FF Isik
Surgery 2000
Apical and non-polarized secretion of serpins from MDCK cells
LK Vogel, JE Larsen
FEBS Letters 2000
Modulation of Endogenous Smad Expression in Normal Skin Fibroblasts by Transforming Growth Factor-β
Y Mori, SJ Chen, J Varga
Experimental Cell Research 2000
Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)
HR Lijnen, B Arza, BV Hoef, D Collen, PJ Declerck
The Journal of biological chemistry 2000
Mechanical stress enhances expression and production of plasminogen activator in aging human periodontal ligament cells
S Miura, M Yamaguchi, N Shimizu, Y Abiko
Mechanisms of Ageing and Development 2000
Importance of the Hinge Region between α-Helix F and the Main Part of Serpins, Based upon Identification of the Epitope of Plasminogen Activator Inhibitor Type 1 Neutralizing Antibodies
AP Bijnens, A Gils, I Knockaert, JM Stassen, PJ Declerck
The Journal of biological chemistry 2000
Structures of Active and Latent PAI-1: A Possible Stabilizing Role for Chloride Ions
TJ Stout, H Graham, DI Buckley, DJ Matthews
Biochemistry 2000
Antisense Oligonucleotide of Tissue Inhibitor of Metalloproteinase-1 Induces the Plasminogen Activator Activity in Periodontal Ligament Cells
Y Shibata, H Takiguchi, Y Abiko
Journal of Periodontology 1999
Urokinase gene expression indicates early invasive growth in squamous cell lesions of the uterine cervix
L Riethdorf, S Riethdorf, S Petersen, M Bauer, H Herbst, F J�nicke, T L�ning
The Journal of Pathology 1999
Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms
T Kirkegaard, S Jensen, SL Schousboe, HH Petersen, R Egelund, PA Andreasen, KW Rodenburg
European Journal of Biochemistry 1999
Evidence that Heparin but Not Hirudin Reduces PAI-1 Expression in Cultured Human Endothelial Cells
J Orbe, R Montes, N Zabalegui, A Pérez-Ruiz, JA Páramo
Thrombosis Research 1999
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor
G Fibbi, M Pucci, C Grappone, G Pellegrini, R Salzano, A Casini, S Milani, MD Rosso
Hepatology 1999
Induction of conformational changes within crystals of plasminogen activator inhibitor-1 (PAI-1)
PK Willems, A Gils, K Aertgeerts, CJ Ranter, PJ Declerck
Fibrinolysis and Proteolysis 1999
Management of Acute Coronary Syndromes
CP Cannon
1999
Enhancement of LPS-stimulated plasminogen activator production in aged gingival fibroblasts
K Mochizuki, M Yamaguchi, Y Abiko
Journal of Periodontal Research 1999
Endothelial cell activation
PB Bal
Kidney International 1998
Effect of Aging on Functional Changes of Periodontal Tissue Cells
Y Abiko, N Shimizu, M Yamaguchi, H Suzuki, H Takiguchi
Annals of Periodontology 1998
Cloning and high-level expression of plasminogen activator inhibitor-1 cDNA derived from human glomerular mesangial cells
Y Deng, X Chen, H Liao, Y Ye, Q Xu, L Yu
Science in China Series C: Life Sciences 1998
Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule
GC Sui, B Wiman
Biochemical Journal 1998
Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor
KW Rodenburg, L Kjoller, HH Petersen, PA Andreasen
Biochemical Journal 1998
Stability of plasminogen activator inhibitor-1: role of tyrosine221
GC Sui, B Wiman
FEBS Letters 1998
Stimulatory effect of interleukin-6 on plasminogen activator activity from human dental pulp cells
S Hosoya, E Ohbayashi, K Matsushima, H Takeuchi, M Yamazaki, Y Shibata, Y Abiko
Journal of Endodontics 1998
Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition
A Gils, N Vleugels, K Tobback, I Knockaert, PJ Declerck
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1998
Thromboxane A 2 modulates the fibrinolytic system in glomerular mesangial cells
TM Coffman, RF Spurney, RB Mannon, R Levenson
American journal of physiology. Renal physiology 1998
Cyclic Nucleotide Regulation of Type-1 Plasminogen Activator-Inhibitor mRNA Stability in Rat Hepatoma Cells: IDENTIFICATION OF cis -ACTING SEQUENCES
JH Heaton, M Tillmann-Bogush, NS Leff, TD Gelehrter
The Journal of biological chemistry 1998
The Structure and Function of Murine Factor V and Its Inactivation by Protein C
TL Yang, J Cui, A Rehumtulla, A Yang, M Moussalli, RJ Kaufman, D Ginsburg
Blood 1998
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD
The Annals of Thoracic Surgery 1997
Low-energy diode laser irradiation reduced plasminogen activator activity in human periodontal ligament cells
Y Ozawa, N Shimizu, Y Abiko
Lasers in Surgery and Medicine 1997
Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1
C Duymelinck, SE Dauwe, EJ Nouwen, ME de Broe, GA Verpooten
Kidney International 1997
TGF-β and the endothelium during immune injury
P Pintavorn, BJ Ballermann
Kidney International 1997
Rational Design of Complex Formation between Plasminogen Activator Inhibitor-1 and Its Target Proteinases
K Aertgeerts, CJ de Ranter, NA Booth, PJ Declerck
Journal of Structural Biology 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
Construction and characterization of plasminogen activator inhibitor-1 mutants in which part of the active site loop is deleted
A Gils, I Knockaert, PJ Declerck
Fibrinolysis and Proteolysis 1997
Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator
P Björquist, J Ehnebom, T Inghardt, J Deinum
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1997
Proteinase Specificity and Functional Diversity in Point Mutants of Plasminogen Activator Inhibitor 1
A Gils, PJ Declerck
The Journal of biological chemistry 1997
Cloning of a single-chain variable fragment (scFv) switching active plasminogen activator inhibitor-1 to substrate
S Debrock, L Sironi, PJ Declerck
Gene 1997
Purification, cDNA Cloning, and Characterization of a New Serpin with Megakaryocyte Maturation Activity
M Tsujimoto, N Tsuruoka, N Ishida, T Kurihara, F Iwasa, K Yamashiro, T Rogi, S Kodama, N Katsuragi, M Adachi, T Katayama, M Nakao, K Yamaichi, J Hashino, M Haruyama, K Miura, T Nakanishi, H Nakazato, M Teramura, H Mizoguchi, N Yamaguchi
The Journal of biological chemistry 1997
Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms
S Debrock, PJ Declerck
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1997
Intracellular Calcium Mobilization Suppresses the TNF-α–Stimulated Synthesis of PAI-1 in Human Endothelial Cells: Indications That Calcium Acts at a Translational Level
F Peiretti, MC Alessi, M Henry, F Anfosso, I Juhan-Vague, G Nalbone
Arteriosclerosis, thrombosis, and vascular biology 1997
Five Frequent Polymorphisms of the PAI-1 Gene: Lack of Association Between Genotypes, PAI Activity, and Triglyceride Levels in a Healthy Population
M Henry, N Chomiki, PY Scarabin, MC Alessi, F Peiretti, D Arveiler, J Ferrières, A Evans, P Amouyel, O Poirier, F Cambien, I Juhan-Vague
Arteriosclerosis, thrombosis, and vascular biology 1997
Plasminogen Activator Inhibitor-1 in Neointima of Vein Grafts: Its Role in Reduced Fibrinolytic Potential and Graft Failure
P Kauhanen, V Sirén, O Carpén, A Vaheri, M Lepäntalo, R Lassila
Circulation 1997
Plasminogen Activator Inhibitor Type 1 and Tissue Inhibitor of Metalloproteinases-2 Increase After Arterial Injury in Rats
D Hasenstab, R Forough, AW Clowes
Circulation research 1997
Moderate Genetic Influences on Plasma Levels of Plasminogen Activator Inhibitor-1 and Evidence of Genetic and Environmental Influences Shared by Plasminogen Activator Inhibitor-1, Triglycerides, and Body Mass Index
Y Hong, NL Pedersen, N Egberg, U de Faire
Arteriosclerosis, thrombosis, and vascular biology 1997
Textbook of Coronary Thrombosis and Thrombolysis
RC Becker
1997
Effect of tension-force on plasminogen activator activity from human periodontal ligament cells
M Yamaguchi, N Shimizu, Y Ozawa, K Saito, S Miura, H Takiguchi, T Iwasawa, Y Abiko
Journal of Periodontal Research 1997
The Suicide Substrate Reaction Between Plasminogen Activator Inhibitor 1 and Thrombin Is Regulated by the Cofactors Vitronectin and Heparin
M van Meijer, A Smilde, G Tans, ME Nesheim, H Pannekoek, AJ Horrevoets
Blood 1997
Review
M Epstein
Renal Failure 1996
Regulation of plasminogen activator inhibitor activity in endothelial cells by tissue-type plasminogen activator
GY Shi, CC Hsu, BI Chang, CF Tsai, HS Han, MD Lai, MT Lin, WC Chang, LY Wing, CJ Jen, MJ Tang, HL Wu
Fibrinolysis 1996
Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa
J Fujimoto, M Hori, S Ichigo, T Tamaya
The Journal of Steroid Biochemistry and Molecular Biology 1996
Ligand-toxin Hybrids Directed to the -Macroglobulin Receptor/Low Density Lipoprotein Receptor-related Protein Exhibit Lower Toxicity than Native Pseudomonas Exotoxin
AG Zdanovsky, MV Zdanovskaia, D Strickland, DJ FitzGerald
The Journal of biological chemistry 1996
Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL
L Sironi, L Mussoni, L Prati, D Baldassarre, M Camera, C Banfi, E Tremoli
Arteriosclerosis, thrombosis, and vascular biology 1996
Sex Steroids Regulate the Expression of Plasminogen Activator Inhibitor-1 and its mRNA in Fibroblasts Derived from Uterine Endometrium
J Fujimoto, M Hori, S Ichigo, T Tamaya
Annals of Clinical Biochemistry 1996
Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1
K Aertgeerts, HL de Bondt, CJ de Ranter, PJ Declerck
Nature Structural Biology 1995
Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts
XC Mu, PJ Higgins
Journal of Cellular Physiology 1995
Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1
K Aertgeerts, HL de Bondt, CD Ranter, PJ Declerck
Proteins: Structure, Function, and Genetics 1995
Inhibition by Modified Oligodeoxynucleotides of the Expression of Type-1 Plasminogen Activator Inhibitor in Human Endothelial Cells
CS Cierniewski, A Babinska, M Swiatkowska, M Wilczynska, A Okruszek, WJ Stec
European Journal of Biochemistry 1995
Retroviral vector–mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells
D Ekhterae, JC Stanley
Journal of Vascular Surgery 1995
Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders
M Butcher, R Frenck, J Emperor, D Paderanga, D Maybee, K Olson, K Shannon
Genes, Chromosomes and Cancer 1995
Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells
MS Hammes, JC Lieske, S Pawar, BH Spargo, FG Toback
Kidney International 1995
Plasminogen Activator Inhibitor-1 in Brain Tumors
R Sawaya, M Yamamoto, OJ Rämö, ML Shi, A Rayford, JS Rao
Neurosurgery 1995
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1
U Reuning, O Wilhelm, T Nishiguchi, L Guerrini, F Blasi, H Graeff, M Schmitt
Nucleic Acids Research 1995
Cloning of the mink plasminogen activator inhibitor type-1 messenger RNA: An mRNA with a short half life
TH Chuang, RT Hamilton, M Nilsen-Hamilton
Gene 1995
Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update
M Meijer, H Pannekoek
Fibrinolysis 1995
Human hepatocytes express the gene for type 1 plasminogen activator-inhibitor (PAI-1) in vivo
AJ Thornton, TD Gelehrter
Fibrinolysis 1995
Characterization of common neoantigenic epitopes generated in plasminogen activator inhibitor-1 after cleavage of the reactive center loop or after complex formation with various serine proteinases
S Debrock, PJ Declerck
FEBS Letters 1995
Recombinant DNA Methodology II
J Chao, KX Chai, L Chao
Recombinant DNA Methodology II 1995
Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes
DI Simon, H Xu, DE Vaughan
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1995
Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms
E Sancho, PJ Declerck, NC Price, SM Kelly, NA Booth
Biochemistry 1995
Identification of Tissue-type Plasminogen Activator-specific Plasminogen Activator Inhibitor-1 Mutants: EVIDENCE THAT SECOND SITES OF INTERACTION CONTRIBUTE TO TARGET SPECIFICITY
PM Sherman, DA Lawrence, IM Verhamme, D Paielli, JD Shore, D Ginsburg
The Journal of biological chemistry 1995
Plasminogen Activator Inhibitor-1 in Brain Tumors: Relation to Malignancy and Necrosis
R Sawaya, M Yamamoto, OJ Rm, ML Shi, A Rayford, JS Rao
Neurosurgery 1995
Lack of Role for Nitric Oxide (NO) in the Selective Destabilization of Endothelial NO Synthase mRNA by Tumor Necrosis Factor–α
F Mohamed, JC Monge, A Gordon, P Cernacek, D Blais, DJ Stewart
Arteriosclerosis, thrombosis, and vascular biology 1995
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance
Vaughan
Journal of Thrombosis and Thrombolysis 1995
Influence of exogenous growth factors on the expression of plasminogen activators and plasminogen activator inhibitors by cells isolated from normal and healing rabbit ligaments
PG Murphy, DA Hart
Journal of Orthopaedic Research 1994
Purification and Characterization of Active and Stable Recombinant Plasminogen-Activator Inhibitor Accumulated at High Levels in Escherichia coli
E Sancho, DW Tonge, RC Hockney, NA Booth
European Journal of Biochemistry 1994
The Role of Progestationally Regulated Stromal Cell Tissue Factor and Type-1 Plasminogen Activator Inhibitor (PAI-1) in Endometrial Hemostasis and Menstruation
CJ Lockwood, G Krikun, C Papp, E Toth, L Markiewicz, EY Wang, T Kerenyi, X Zhou, V Hausknecht, Z Papp, F Schatz
Annals of the New York Academy of Sciences 1994
Mechanisms of plasminogen activation
HR Lijnen, F Bachmann, D Collen, V Ellis, H Pannekoek, DC Rijken, S Thorsen
Journal of Internal Medicine 1994
Vascular Endothelium
MA Gimbrone, MI Cybulsky, N Kume, T Collins, N Resnick
Annals of the New York Academy of Sciences 1994
Probing structure-function relationships of tissue-type plasminogen activator by site-specific mutagenesis
EL Madison
Fibrinolysis 1994
Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI-1)
M Meijer, RK Gebbink, KT Preissner, H Pannekoek
FEBS Letters 1994
Processing of type 1 plasminogen activator inhibitor (PAI-1) into the regulated secretory pathway
L Gombau, RR Schleef
The Journal of biological chemistry 1994
Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response
AM Healy, TD Gelehrter
The Journal of biological chemistry 1994
Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop
AM Audenaert, I Knockaert, D Collen, PJ Declerck
The Journal of biological chemistry 1994
Plasminogen activator inhibitor 1, the primary regulator of fibrinolysis, in normal human cerebrospinal fluid
JS Rao, M Chen, BW Festoff
Journal of Neuroscience Research 1993
Contribution of sinusoidal endothelial liver cells to liver fibrosis: Expression of transforming growth factor-β1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-β1
H Rieder, T Armbrust, KH Büschenfelde, G Ramadori
Hepatology 1993
Species-specific differential cleavage and polyadenylation of plasminogen activator inhibitor type 1 hnRNA
PG Fattal, JJ Billadello
Nucleic Acids Research 1993
Different fibrinolytic potential in cultured human adult and umbilical vein endothelial cells
V Arnman, L Rymo, B Risberg
Fibrinolysis 1993
Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1)
DE Vaughan, PJ Declerck, TM Reilly, K Park, D Collen, GD Fasman
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1993
Plasminogen activators and plasminogen activator inhibitors in connective tissues and connective tissue cells: influence of the neuropeptide substance P on expression
PG Murphy, DA Hart
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1993
Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288
BA Konkle, PK Schick, X He, RJ Liu, EM Mazur
Arteriosclerosis Thrombosis and Vascular Biology 1993
Converting Tissue Plasminogen Activator to a Zymogen: A Regulatory Triad of Asp-His-Ser
EL Madison, A Kobe, MJ Gething, JF Sambrook, EJ Goldsmith
Science 1993
Isolation and characterization of an intracellular serine proteinase inhibitor from a monkey kidney epithelial cell line
KA Morgenstern, WJ Henzel, JB Baker, S Wong, A Pastuszyn, W Kisiel
The Journal of biological chemistry 1993
The plasminogen-plasmin system in malignancy
HC Kwaan
Cancer and Metastasis Reviews 1992
Expression of plasminogen activator and plasminogen activator inhibitor mRNA in human fibroblasts grown on different substrates
J Varani, RG Sitrin, W Hillegas
Cytotechnology 1992
Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation
WP Fay, AD Shapiro, JL Shih, RR Schleef, D Ginsburg
New England Journal of Medicine 1992
LOCALIZATION OF COMPONENTS FROM THE PLASMINOGEN ACTIVATION SYSTEM IN MAMMALIAN TISSUES
P Kristensen
APMIS 1992
Purification and characterisation of recombinant rabbit plasminogen activator inhibitor-1 expressed in Saccharomyces cerevisiae
KJ Hofmann, EJ Mayer, LD Schultz, SH Socher, CF Reilly
Fibrinolysis 1992
Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators
P Murphy, DA Hart
Experimental Cell Research 1992
Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells
MN Peraldi, E Rondeau, RL Medcalf, J Hagège, R Lacave, D Françoise, WD Schleuning, JD Sraer
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1992
Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1: identification, characterization and regulation by inflammatory mediators
A Arndt, P Murphy, DA Hart
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1992
Angiogenesis in Health and Disease
ME Maragoudakis, P Gullino, PI Lelkes
1992
Protein Pharmacokinetics and Metabolism
BL Ferraiolo, MA Mohler, CA Gloff
1992
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center
PM Sherman, DA Lawrence, AY Yang, ET Vandenberg, D Paielli, ST Olson, JD Shore, D Ginsburg
The Journal of biological chemistry 1992
Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha
BC Marshall, QP Xu, NV Rao, BR Brown, JR Hoidal
The Journal of biological chemistry 1992
A major estrogen-regulated protein secreted from the liver of Xenopus laevis is a member of the serpin superfamily. Nucleotide sequence of cDNA and hormonal induction of mRNA
LJ Holland, C Suksang, AA Wall, LR Roberts, DR Moser, A Bhattacharya
The Journal of biological chemistry 1992
Differential Expression of Urokinase-Type Plasminogen Activator and Its Type-1 Inhibitor During Healing of Mouse Skin Wounds
J Romer, LR Lund, J Eriksen, E Ralfkiaer, R Zeheb, TD Gelehrter, K Dano, P Kristensen
Journal of Investigative Dermatology 1991
Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor
M Mawatari, K Okamura, T Matsuda, R Hamanaka, H Mizoguchi, K Higashio, K Kohno, M Kuwano
Experimental Cell Research 1991
Cartilage synthesizes the serine protease inhibitor PAI-1: Support for the involvement of serine proteases in cartilage remodeling
BV Treadwell, M Pavia, CA Towle, VJ Cooley, HJ Mankin
Journal of Orthopaedic Research 1991
Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix
HJ Ehrlich, RK Gebbink, KT Preissner, J Keijer, NL Esmon, K Mertens, H Pannekoek
The Journal of Cell Biology 1991
The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein
ME Mendelsohn, Y Zhu, S O'Neill
Proceedings of the National Academy of Sciences 1991
Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence
S Murano, R Thweatt, RJ Reis, RA Jones, EJ Moerman, S Goldstein
Molecular and cellular biology 1991
Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence
C Hassett, RJ Richter, R Humbert, C Chapline, JW Crabb, CJ Omiecinski, CE Furlong
Biochemistry 1991
Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator
K Bartha, PJ Declerck, H Moreau, L Nelles, D Collen
The Journal of biological chemistry 1991
Combinatorial mutagenesis of the reactive site region in plasminogen activator inhibitor I
JD York, P Li, SJ Gardell
The Journal of biological chemistry 1991
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator
J Keijer, HJ Ehrlich, M Linders, KT Preissner, H Pannekoek
The Journal of biological chemistry 1991
Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells
PJ Bosma, T Kooistra
The Journal of biological chemistry 1991
Plasminogen activator inhibitors: hormonally regulated serpins
PA Andreasen, B Georg, LR Lund, A Riccio, SN Stacey
Molecular and Cellular Endocrinology 1990
Transforming Growth Factor-? in Psoriasis: Pathogenesis and Therapy
JT Elder, LR Ellingsworth, GJ Fisher, JJ Voorhees
Annals of the New York Academy of Sciences 1990
Transforming Growth Factor-beta Modulates Plasminogen Activator Activity and Plasminogen Activator Inhibitor Type-1 Expression in Human Keratinocytes In Vitro
NE Wikner, JT Elder, KA Persichitte, P Mink, RA Clark
Journal of Investigative Dermatology 1990
Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells
B Georg, A Riccio, P Andreasen
Molecular and Cellular Endocrinology 1990
Modulation of levels of messenger RNA for tissue-type plasminogen activator in rat Sertoli cells, and levels of messenger RNA for plasminogen activator inhibitor in testis peritubular cells
C Nargolwalla, D McCabe, IB Fritz
Molecular and Cellular Endocrinology 1990
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
DJ Loskutoff, SA Curriden
Annals of the New York Academy of Sciences 1990
Conformational differences between latent and active plasminogen activator inhibitor, PAI-1: A spectroscopic study
S Boström, J Deinum, JE Löfroth, M Wirth, M Kubista
Thrombosis Research 1990
Stabilisation of plasminogen activator inhibitor type 1 (PAI-1) activity by arginine: Possible implications for the interaction of PAI-1 with vitronectin
J Keijer, M Linders, H Ehrlich, RK Gebbink, H Pannekoek
Fibrinolysis 1990
Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1
AE Franke, DE Danley, FS Kaczmarek, SJ Hawrylik, RD Gerard, SE Lee, KF Geoghegan
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1990
Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo
DE Vaughan, PJ Declerck, EV Houtte, MD Mol, D Collen
Circulation research 1990
Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium
BA Konkle, SS Shapiro, AS Asch, RL Nachman
The Journal of biological chemistry 1990
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties
HJ Ehrlich, RK Gebbink, J Keijer, M Linders, KT Preissner, H Pannekoek
The Journal of biological chemistry 1990
Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways
BA Konkle, PR Kollros, MD Kelly
The Journal of biological chemistry 1990
Isolation and characterization of the rat plasminogen activator inhibitor-1 gene
CJ Bruzdzinski, M Riordan-Johnson, EC Nordby, SM Suter, TD Gelehrter
The Journal of biological chemistry 1990
Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli
TM Reilly, R Seetharam, JL Duke, GL Davis, SK Pierce, HL Walton, D Kingsley, WP Sisk
The Journal of biological chemistry 1990
Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma
P Kristensen, C Pyke, LR Lund, PA Andreasen, K Dan
Histochemistry 1990
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor
RR Schleef, DL Higgins, E Pillemer, LJ Levitt
Journal of Clinical Investigation 1989
A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide
WF Bahou, D Ginsburg, R Sikkink, R Litwiller, DN Fass
Journal of Clinical Investigation 1989
Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits
DE Vaughan, PJ Declerck, MD Mol, D Collen
Journal of Clinical Investigation 1989
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger an
OF Wagner, C Vries, C Hohmann, H Veerman, H Pannekoek
Journal of Clinical Investigation 1989
Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7
KM Shannon, AG Turhan, SS Chang, AM Bowcock, PC Rogers, WL Carroll, MJ Cowan, BE Glader, CJ Eaves, AC Eaves
Journal of Clinical Investigation 1989
Tumor necrosis factor-α regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines
B Georg, E Helseth, LR Lund, T Skandsen, A Riccio, K Dane, G Unsgaard, PA Andreasen
Molecular and Cellular Endocrinology 1989
Determination of Exon–Intron Structure: A Novel Application of the Polymerase Chain Reaction Technique
CJ Bruzdzinski, TD Gelehrter
DNA 1989
Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells
D LAWRENCE, L STRANDBERG, T GRUNDSTROM, T NY
European Journal of Biochemistry 1989
Characterization of Keratinocyte Plasminogen Activator Inhibitors and Demonstration of the Prevention of Pemphigus IgG-induced Acantholysis by a Purified Plasminogen Activator Inhibitor
K Hashimoto, TC Wun, J Baird, GS Lazarus, PJ Jensen
Journal of Investigative Dermatology 1989
Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils
E Remold-O'Donnell, JC Nixon, RM Rose
Journal of Experimental Medicine 1989
Plasminogen activator inhibitor-type I is a major biosynthetic product of retinal microvascular endothelial cells and pericytes in culture
AE Canfield, AM Schor, DJ Loskutoff, SL Schor, ME Grant
Biochemical Journal 1989
RFLP for Sst I (Sac I) at the human plasminogen activator inhibitor type 1 (PAI-1) gene locus
I Kondo, K Berg
Nucleic Acids Research 1989
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor
MV Cubellis, P Andreasen, P Ragno, M Mayer, K Danø, F Blasi
Proceedings of the National Academy of Sciences 1989
Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma
Y Ke, RR Reddel, BI Gerwin, HK Reddel, AN Somers, MG McMenamin, MA LaVeck, RA Stahel, JF Lechner, CC Harris
The American Journal of Pathology 1989
Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1
M Follo, D Ginsburg
Gene 1989
Plasminogen activator inhibitor type 2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted
T Ny, L Hansson, D Lawrence, G Leonardsson, B Åstedt
Fibrinolysis 1989
The role of ovarian proteases and their inhibitors in ovulation
TE Curry, DD Dean, SL Sanders, NG Pedigo, PB Jones
Steroids 1989
Sodium-N-butyrate induces secretion and substrate accumulation of p52 in kirsten sarcoma virus-transformed rat kidney fibroblasts
MP Ryan, PJ Higgins
International Journal of Biochemistry 1989
Serpin-resistant mutants of human tissue-type plasminogen activator
EL Madison, EJ Goldsmith, RD Gerard, MJ Gething, JF Sambrook
Nature 1989
Plasminogen activator inhibitor (type-1) in rat adrenal medulla
J Eriksen, P Kristensen, C Pyke, K Dan
Histochemistry 1989
CpG Mutations in the Reactive Site of Human C 1¯ Inhibitor
K Skriver, E Radziejewska, JA Silbermann, VH Donaldson, SC Bock
The Journal of biological chemistry 1989
Regulation of Type 1 Plasminogen Activator Inhibitor Gene Expression in Cultured Bovine Aortic Endothelial Cells
M Sawdey, TJ Podor, DJ Loskutoff
The Journal of biological chemistry 1989
Regulation of endothelial cell coagulant properties
EM Scarpati, JE Sadler
The Journal of biological chemistry 1989
Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase
TC Wun, MO Palmier, NR Siegel, CE Smith
The Journal of biological chemistry 1989
Structure of the Gene for Human Plasminogen Activator Inhibitor-2
RD Ye, SM Ahern, MM Beau, RV Lebo, JE Sadler
The Journal of biological chemistry 1989
Variability in messenger RNA levels in human umbilical vein endothelial cells of different lineage and time in culture
D Dichek, T Quertermous
In Vitro Cellular & Developmental Biology – Animal 1989
The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression
BA Konkle, D Ginsburg
Journal of Clinical Investigation 1988
Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines, as determined by enzyme-linked immunosorbent assay
LR Lund, B Georg, LS Nielsen, M Mayer, K Danø, PA Andreasen
Molecular and Cellular Endocrinology 1988
Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo
J Grondahl-Hansen, LR Lund, E Ralfkiaer, V Ottevanger, K Dano
Journal of Investigative Dermatology 1988
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2
S THORSEN, M PHILIPS, J SELMER, I LECANDER, B ASTEDT
European Journal of Biochemistry 1988
Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1)
MC ALESSI, PJ DECLERCK, M MOL, L NELLES, D COLLEN
European Journal of Biochemistry 1988
The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family
L STRANDBERG, D LAWRENCE, T NY
European Journal of Biochemistry 1988
Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation
K KATAGIRI, K OKADA, H HATTORI, M YANO
European Journal of Biochemistry 1988
Transforming growth factor-β1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines
E Helseth, A Dalen, G Unsgaard, T Skandsen, J GrØNdahl-Hansen, LR Lund
APMIS 1988
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor
TM Antalis, MA Clark, T Barnes, PR Lehrbach, PL Devine, G Schevzov, NH Goss, RW Stephens, P Tolstoshev
Proceedings of the National Academy of Sciences 1988
The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene
A Riccio, LR Lund, R Sartorio, A Lania, PA Andreasen, K Danø, F Blasi
Nucleic Acids Research 1988
Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1
R Zeheb, TD Gelehrter
Gene 1988
Surface receptors for urokinase plasminogen activator
F Blasi
Fibrinolysis 1988
Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function
DA Hart, A Rehemtulla
Comparative Biochemistry and Physiology Part B: Comparative Biochemistry 1988
Immunohistochemical localization of urokinase-type plasminogen activator in sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium
KK Vihko, P Kristensen, K Danø, M Parvinen
Developmental Biology 1988
International Review of Experimental Pathology
P Hoedemaeker
International Review of Experimental Pathology 1988
Mutants of human tissue-type plasminogen activator (t-PA): Structural aspects and functional properties
H Pannekoek, C Vries, AJ Zonneveld
Fibrinolysis 1988
Purification and characterization of placental protein 5
R Bützow, ML Huhtala, H Bohn, I Virtanen, M Seppälä
Biochemical and Biophysical Research Communications 1988
Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA): a comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins
CD Vries, H Veerman, F Blasi, H Pannekoek
Biochemistry 1988
Bovine plasminogen activator inhibitor 1: Specificity determinations and comparison of the active, latent, and guanidine-activated forms
CM Hekman, DJ Loskutoff
Biochemistry 1988
Genetic markers on chromosome 7
LC Tsui
Journal of medical genetics 1988
Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences
PJ Bosma, EA van den Berg, T Kooistra, DR Siemieniak, JL Slightom
The Journal of biological chemistry 1988
Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor
CL Lucore, S Fujii, TC Wun, BE Sobel, JJ Billadello
The Journal of biological chemistry 1988
Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
RR Schleef, MP Bevilacqua, M Sawdey, MA Gimbrone, DJ Loskutoff
The Journal of biological chemistry 1988
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells
J Keski-Oja, R Raghow, M Sawdey, DJ Loskutoff, AE Postlethwaite, AH Kang, HL Moses
The Journal of biological chemistry 1988
Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells
M Mayer, LR Lund, A Riccio, J Skouv, LS Nielsen, SN Stacey, K Danø, PA Andreasen
The Journal of biological chemistry 1988
Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor
AC Webb, KL Collins, SE Snyder, SJ Alexander, LJ Rosenwasser, RL Eddy, TB Shows, PE Auron
Journal of Experimental Medicine 1987
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
F Blasi, JD Vassalli, K Danø
The Journal of Cell Biology 1987
Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors
GL Hammond, CL Smith, IS Goping, DA Underhill, MJ Harley, J Reventos, NA Musto, GL Gunsalus, CW Bardin
Proceedings of the National Academy of Sciences 1987
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells
PA Andreasen, C Pyke, A Riccio, P Kristensen, LS Nielsen, LR Lund, F Blasi, K Danø
Molecular and cellular biology 1987
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts
LR Lund, A Riccio, PA Andreasen, LS Nielsen, P Kristensen, M Laiho, O Saksela, F Blasi, K Danø
The EMBO Journal 1987
Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis
KW Klinger, R Winqvist, A Riccio, PA Andreasen, R Sartorio, LS Nielsen, N Stuart, P Stanislovitis, P Watkins, R Douglas
Proceedings of the National Academy of Sciences 1987
Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells
DJ Crutchley, LB Conanan, US Ryan
Biochemical and Biophysical Research Communications 1987
Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns
DJ Loskutoff, M Linders, J Keijer, H Veerman, HV Heerikhuizen, H Pannekoek
Biochemistry 1987
Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids
JW Lambers, M Cammenga, BW König, K Mertens, H Pannekoek, JA van Mourik
The Journal of biological chemistry 1987
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta
RD Ye, TC Wun, JE Sadler
The Journal of biological chemistry 1987
Clinical Chemistry
RM Archibald
Analytical Chemistry 1953

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 16 patents
22 readers on Mendeley
See more details